|
Nirupama Pike PhD
Sr. Director, Global Head of Strategic Alliances and Field Scientists, Cell Therapy
Catalent Pharma Solutions
|
Rupa is the Sr. Director and Global Head of Strategic Alliances and Field Scientists for Cell Therapy at Catalent where she is responsible for accelerating cell therapy business through innovative partnerships. Rupa has over 15 years of cell therapy expertise in GMP manufacturing and has successfully led GMP operations, process development, training, infrastructure buildout, customer relations and business development activities. Most recently, Rupa worked at Thermo Fisher Scientific, where she held several key leadership roles during her tenure, including Sr. Director of Technical Affairs for Advanced Therapies, Head of Technical Operations and Director of Enterprise Science and Innovation Partnerships. She worked closely with BioPharma, Biotech and Healthcare customers to advance cell-based therapies from discovery and development to clinical gmp manufacturing. She also served as the Director of Cell Manufacturing for Program for Advanced Cell Therapy at UW Hospitals and Clinics. At Ligand Pharmaceuticals, she was part of the team that designed novel hematopoietic screening assays for erythropoietin and thrombopoietin in partnership with GlaxoSmithKline, a part of the program that led to development of Promacta®, a drug for the treatment of chronic immune thrombocytopenic purpura.
Rupa holds a master’s degree in biology from Loyola University and a doctorate from Harvard University with focus on immunology and hematology.
Rupa holds a master’s degree in biology from Loyola University and a doctorate from Harvard University with focus on immunology and hematology.